Cartesian Therapeutics, Inc. RNAC NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score

56/100

3/7 Pass

SharesGrow Intrinsic Value

Ha habido 50 transacciones internas recientes registradas para Cartesian Therapeutics, Inc. (RNAC), incluyendo 25 compras y 21 ventas. El total de compras internas fue valorado en $5.23M y el total de ventas internas en $967.74K.

Internos destacados con actividad reciente incluyen Kalayoglu Murat, Hoge Elizabeth, Singer Michael. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.

Operaciones de Insiders — RNAC

Fecha	Nombre	Cargo	Tipo de Transacción	Acciones	Precio Promedio	Valor	Acciones en Propiedad
2026-04-02	Kalayoglu Murat	10 Percent Owner	Ejercicio de Opciones (Venta)	22,740	-	-	33,662
2026-04-02	Hoge Elizabeth	10 Percent Owner	Ejercicio de Opciones (Venta)	22,740	-	-	33,662
2026-03-13	Singer Michael	Director	Donación (Otorgada)	6,555	-	-	49,578
2026-01-06	Brunn Carsten	President and CEO	Venta Informativa	23,766	$6.82	$162.08K	323,530
2026-01-06	Davis Blaine	Chief Financial Officer	Venta Informativa	10,591	$6.82	$72.23K	121,220
2026-01-06	Miljkovic Milos	Chief Medical Officer	Venta Informativa	3,573	$6.82	$24.37K	58,820
2026-01-02	Springer Timothy A	10 Percent Owner	Concesión de RSU	7,800	$6.76	$52.73K	7,800
2026-01-02	Zenner Patrick J	Director	Concesión de RSU	7,800	$6.76	$52.73K	7,800
2026-01-02	Barabe Timothy C	Director	Concesión de RSU	7,800	$6.76	$52.73K	7,800
2026-01-02	Desilva Nishan M	Director	Concesión de RSU	7,800	$6.76	$52.73K	7,800
2026-01-02	Brunn Carsten	President and CEO	Concesión de RSU	143,200	-	-	347,296
2026-01-02	Malik Kemal	Director	Concesión de RSU	7,800	$6.76	$52.73K	7,800
2026-01-02	Davis Blaine	Chief Financial Officer	Concesión de RSU	109,000	$6.76	$736.84K	109,000
2026-01-02	Kalayoglu Murat	10 Percent Owner	Concesión de RSU	7,800	$6.76	$52.73K	7,800
2026-01-02	Singer Michael	Director	Concesión de RSU	7,800	$6.76	$52.73K	7,800
2026-01-02	Miljkovic Milos	Chief Medical Officer	Concesión de RSU	27,000	-	-	62,393
2026-01-02	English Emily	Chief Operations Officer	Concesión de RSU	71,000	$6.76	$479.96K	71,000
2026-01-02	Seymour June Ann	Chief Accounting Officer	Concesión de RSU	6,500	-	-	6,500
2025-12-30	English Emily	Chief Operations Officer	Ejercicio de Opciones (Venta)	7,500	$3.30	$24.75K	19,369
2025-12-16	Bot Adrian Ion	Director	Desconocido	-	-	-	-
2025-12-16	Bot Adrian Ion	Director	Concesión de RSU	5,800	-	-	5,800
2025-12-04	Barabe Timothy C	Director	Compra Informativa	30,000	$6.86	$205.8K	54,366
2025-11-28	English Emily	Chief Operations Officer	Ejercicio de Opciones (Venta)	7,500	$3.30	$24.75K	26,869
2025-11-18	Singer Michael	Director	Donación (Otorgada)	20,000	-	-	53,533
2025-10-27	Seymour June Ann	Officer	Desconocido	-	-	-	-
2025-10-27	Seymour June Ann	Chief Accounting Officer	Concesión de RSU	50,000	$8.85	$442.5K	50,000
2025-05-12	English Emily	Chief Operations Officer	Ejercicio de Opciones (Venta)	7,500	$3.30	$24.75K	34,369
2025-04-15	English Emily	Chief Operations Officer	Ejercicio de Opciones (Venta)	7,500	$3.30	$24.75K	41,869
2025-04-11	Springer Timothy A	10 Percent Owner	Compra Informativa	36,338	$10.77	$391.45K	656,513
2025-04-10	Springer Timothy A	10 Percent Owner	Compra Informativa	45,144	$10.43	$471.06K	616,724
2025-04-09	Springer Timothy A	10 Percent Owner	Compra Informativa	41,604	$9.43	$392.18K	571,402
2025-03-20	Springer Timothy A	10 Percent Owner	Compra Informativa	54,889	$15.59	$855.59K	8,621,325
2025-03-19	Springer Timothy A	10 Percent Owner	Compra Informativa	20,234	$14.97	$302.96K	8,566,436
2025-03-18	Springer Timothy A	10 Percent Owner	Compra Informativa	14,740	$14.42	$212.6K	8,546,202
2025-01-14	Springer Timothy A	10 Percent Owner	Compra Informativa	4,022	$18.00	$72.4K	8,531,462
2025-01-13	Springer Timothy A	10 Percent Owner	Compra Informativa	7,962	$16.86	$134.22K	8,518,457
2025-01-10	Jewell Christopher M	Chief Scientific Officer	Ejercicio de Opciones	9,000	$3.23	$29.07K	62,490
2025-01-06	Brunn Carsten	President and CEO	Venta Informativa	8,708	$16.83	$146.57K	204,096
2025-01-06	Davis Blaine	Chief Financial Officer	Venta Informativa	4,028	$16.83	$67.8K	94,811
2025-01-06	Jewell Christopher M	Chief Scientific Officer	Venta Informativa	1,286	$16.83	$21.65K	53,490
2025-01-06	Miljkovic Milos	Chief Medical Officer	Venta Informativa	948	$16.83	$15.96K	35,393
2025-01-06	Kurtoglu Metin	Chief Technology Officer	Venta Informativa	2,458	$16.83	$41.37K	62,258
2025-01-06	English Emily	Chief Operations Officer	Venta Informativa	906	$16.83	$15.25K	40,226
2025-01-03	Brunn Carsten	President and CEO	Venta Informativa	8,563	$16.72	$143.19K	212,804
2025-01-03	Davis Blaine	Chief Financial Officer	Venta Informativa	3,961	$16.72	$66.24K	98,839
2025-01-03	Jewell Christopher M	Chief Scientific Officer	Venta Informativa	1,264	$16.72	$21.14K	54,776
2025-01-03	Miljkovic Milos	Chief Medical Officer	Venta Informativa	932	$16.72	$15.58K	36,341
2025-01-03	Kurtoglu Metin	Chief Technology Officer	Venta Informativa	2,417	$16.72	$40.42K	64,716
2025-01-03	English Emily	Chief Operations Officer	Venta Informativa	891	$16.72	$14.9K	41,132
2025-01-02	Springer Timothy A	10 Percent Owner	Concesión de RSU	7,800	$16.93	$132.05K	7,800

■ Informativa — transacción en mercado abierto (más significativa) ■ No informativa (compra) — premio, ejercicio de opción, conversión ■ No informativa (venta) — retención fiscal, venta de adjudicación ■ Neutral — regalo, fideicomiso, vencimiento